HealthEquity, Inc. - Common Stock (HQY)
97.41
+0.33 (0.34%)
NASDAQ · Last Trade: Jul 23rd, 1:32 AM EDT
Detailed Quote
Previous Close | 97.08 |
---|---|
Open | 97.21 |
Bid | 97.55 |
Ask | 98.00 |
Day's Range | 97.21 - 98.75 |
52 Week Range | 65.01 - 116.65 |
Volume | 647,335 |
Market Cap | 8.12B |
PE Ratio (TTM) | 71.10 |
EPS (TTM) | 1.4 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 938,514 |
Chart
About HealthEquity, Inc. - Common Stock (HQY)
Healthequity is a leading provider of health savings accounts and other consumer-directed benefits, facilitating individuals and employers in managing healthcare expenses. The company offers a robust platform that integrates various services, including healthcare spending accounts, wellness services, and insurance products, aimed at empowering consumers to make informed healthcare decisions. By promoting cost-saving strategies and enhancing access to critical healthcare resources, Healthequity plays a vital role in the healthcare ecosystem, making it easier for users to navigate their financial responsibilities associated with medical care. Read More
News & Press Releases
HEALTHEQUITY INC (HQY) shows strong growth fundamentals and a promising technical setup, making it a stock to watch for breakout potential.
Via Chartmill · July 5, 2025
Via Benzinga · June 27, 2025
Via Benzinga · June 18, 2025
Via Benzinga · June 9, 2025

Via Benzinga · June 5, 2025

Via Benzinga · June 4, 2025

Via Benzinga · June 4, 2025

Via Benzinga · June 4, 2025

Via Benzinga · June 4, 2025

Here's a look at HealthEquity's first-quarter earnings report.
Via Benzinga · June 3, 2025

HEALTHEQUITY INC (NASDAQ:HQY) shows strong growth fundamentals and a bullish technical setup, making it a stock to watch for investors seeking growth opportunities.
Via Chartmill · May 28, 2025
Via Benzinga · May 23, 2025
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · May 19, 2025
Via Benzinga · May 13, 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 9, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 5, 2025
Via Benzinga · May 1, 2025
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · April 29, 2025